Evidence map›Paper›PMID 40498078›Full record

ArticleNucleic acids research2025

A temperature-driven DNA discrimination strategy to distinguish E. coli DNA and phage 5hmC-modified DNA.

Yue Kang, Yahui Liu, Haolong Zhou, Biyun Ma, Huan Chen, Kaining Zhang, Yawen Wang, Chengpeng Fan, Huaiyu Yang, Yingqi Xu and 4 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yue KangDepartment of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.
Yahui LiuDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China.
Haolong ZhouState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
Biyun MaDepartment of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.
Huan ChenDepartment of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.
Kaining ZhangDepartment of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.
Yawen WangDepartment of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.
Chengpeng FanDepartment of Biochemistry and Molecular Biology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, 430072, China.
Huaiyu YangBioCrystallisation Lab, Chemical Engineering Department, Loughborough University, Loughborough LE11 3TU, United Kingdom.
Yingqi XuDepartment of Life Sciences, Imperial College London, London, SW7 2AZ, United Kingdom.
Steve MatthewsDepartment of Life Sciences, Imperial College London, London, SW7 2AZ, United Kingdom.
Shuai YuanState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.ORCID 0000-0003-4037-3429
Yan LiDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China.
Bing LiuDepartment of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, China.ORCID 0000-0003-1670-6115

Funding

Fundamental Research Funds for the Central Universities xtr052023011National Key R&D Program of China 021YFA1301201National Natural Science Foundation of China 32270151
6 · The paper itself

Abstract

The arms race between phages and bacteria is dynamic and ongoing, with both continuously acquiring new strategies to outcompete each other during co-evolution. Here, we report bacteriophage T4 exonuclease DexA and an uncharacterized Escherichia coli exonuclease as a rare pair of attack and defense duo arising from the same mechanism. DexA, highly conserved among phages, has two well-characterized biological roles: host DNA scavenging and intron homing. Unmodified DNA is the substrate during host DNA scavenging, whereas cleavage of 5hmC (5-hydroxymethylcytosine)-modified phage DNA is required for intron homing. We reveal a temperature-driven quaternary fold switch between DexA dimer and tetramer that facilitates cleavage of distinct DNA forms, namely 5hmC-modified phage DNA and unmodified host DNA. As a countermeasure, bacteria produce DexA variants for defense against phage that only targets 5hmC-modified DNA. Thus, both phages and bacteria compete using HmC-Recognizing EXonuclease strategies (designated as HREX).

Indexed as

5-MethylcytosineBacteriophage T4DNA, BacterialDNA, ViralEscherichia coliExodeoxyribonucleasesViral ProteinsEscherichia coli ProteinsIntronsTemperature5-hydroxymethylcytosine5-MethylcytosineDNA, BacterialDNA, ViralEscherichia coli ProteinsExodeoxyribonucleasesViral Proteins

Identifiers

PMID40498078
PMCPMC12153337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.